EBPS Biennial - Maastricht, 13-16 July 2021

We hope all of you are keeping safe and healthy at this time. While the future still looks a little uncertain, we believe that it is important to continue on with our plans to reunite EBPS members at the next biennial to be held in the picturesque city of Maastricht in July of 2021. Together with the local organising committee, we are working on an exciting scientific program for this meeting on recent advances in behavioural pharmacology and related disciplines. The conference symposia will cover diverse topics in pharmacology, psychology, psychiatry, and neuroscience on cellular, genetic, pharmacological, and neural circuit mechanisms of behaviour in both animal models and human subjects.


We are excited to announce our call for symposium proposals and encourage you to submit to contribute to the meeting’s success. If you have any suggestions to stimulate scientific discussions, we welcome you to propose other formats as well. We will give priority to proposals covering novel topics that were not represented in previous EBPS meetings and with a diverse panel of speakers (in consideration of race, gender, and geography) who have not presented at past meetings. Proposals should be submitted to the website by the 1st of October. We will announce the selected symposia in December 2020. 

We look forward to receiving your proposals.

Message from EBPS President, Prof. Louk Vanderschuren

Dear Members,


Please follow this link to a message from our president, Prof. Louk Vanderschuren, in regards to the developing events in the USA and across other parts of the world.


As always, stay safe, take care of and respect each other.

COVID-19: A Message from EBPS President, Prof. Louk Vanderschuren

Dear Members,

Please follow this link to access a letter from our president, Prof. Louk Vanderschuren on the current pandemic and what it might mean for future EBPS events this year.

Take care of yourselves and stay in touch with each other.

EBPS Newsletter Issue 8

Grab the latest issue of our society's newsletter here! It features a profile on Markus Heilig, who is our most recent addition to the EBPS full committee, a profile on WFH experiences by Louk Vanderschuren, Shelly Flagel and John Cryan plus a Psychopharmacology paper report by Jordan Carter and Carmela Reichel from the Medical University of South Carolina. We hope you enjoy the read!

Download it here!

EBPS Membership Renewal

Dear EBPS Members,


This reminder is to inform you that it is time to renew your membership for 2020. 


Given the running costs of the society, and to ensure we are able to continue to plan and organise high-quality events for members in the future, the EBPS Executive Committee has decided to increase the annual membership fee. The new membership fee for members has been set to €100, and that for students and post-doctoral researchers is €40 (note that post-doctoral researchers previously paid full membership, so their fee has actually decreased).


Below are the benefits of EBPS membership:

-Free membership of FENS, which includes reduced registration fees for FENS meetings-

-Free online access to European Journal of Neuroscience

-Free online access to Psychopharmacology

-Eligibility to apply for bursaries to attend EBPS workshops and biennial meetings (subject to training status)

-Eligibility to submit symposium proposals for biennial meetings

-Eligibility to nominate, and to be nominated, for the EBPS Distinguished Achievement Award and the EBPS Young Scientist Award

-Reduced registration fees for EBPS meetings, including the upcoming 2020 EBPS Workshop in Toronto


To renew your membership, please click here.


If you prefer to renew your membership by electronic bank transfer, please contact treasurer@ebps.org for EBPS bank details.


We thank you for your support and look forward to seeing you at upcoming events.


With best wishes,

Mohammed Shoaib

Treasurer - EBPS

Special issue: Neuroimmune signaling in neuropsychiatric disease

It is our pleasure to introduce this Special Issue of Psychopharmacology focused on “Neuroimmune Signaling in Neuropsychiatric Disease”. This issue contains recent work from established and emerging thought leaders in the field that contributes to our understanding of the role of neuroimmune signaling. We thank them for their efforts and contributions to the journal.


The innate immune system is implicated and activated in virtually every neuropsychiatric condition, but our understanding of the role of these processes in disease is poorly understood. Neuroimmune signaling can involve both pro-inflammatory and anti-inflammatory processes that in turn can alter neurotransmission at multiple sites. This represents a new frontier in our understanding of normal and pathological brain function, as well as the relationship between systemic and CNS disease. We believe this Special Issue will contribute to the important insights that the study of neuroimmune signaling can afford us into the etiology of CNS disease and the identification of new targets for treatment.


We hope you enjoy the contributions in this issue and that they help inspire you to address neuroimmune signaling in your research.



Editors: A. Leslie Morrow and Lawrence H. Price

Psychopharmacology in its 60th Year!

Professors Klaus Miczek and Trevor Robbins have teamed up to provide their perspective on how the field of psychopharmacology has changed over the last 60 years and the important roles that the EBPS and the journal, Psychopharmacology, have played in this regard.

Click here to access.